These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 9696136
21. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME, Cabiedes J, Reyes E, Cabral AR. Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [Abstract] [Full Text] [Related]
22. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745 [Abstract] [Full Text] [Related]
23. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population. Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C. Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423 [Abstract] [Full Text] [Related]
24. Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies. Le Querrec A, Arnout J, Arnoux D, Borg JY, Caron C, Darnige L, Delahousse B, Reber G, Sié P. Thromb Haemost; 2001 Aug; 86(2):584-9. PubMed ID: 11522007 [Abstract] [Full Text] [Related]
26. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
27. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Kitani T, Iwatani Y, Kanakura Y. Br J Haematol; 2001 Sep; 114(3):647-54. PubMed ID: 11552993 [Abstract] [Full Text] [Related]
28. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE. Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978 [Abstract] [Full Text] [Related]
29. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C. Noordermeer T, Chemlal S, Jansma JJ, van der Vegte V, Schutgens REG, Limper M, de Groot PG, Meijers JCM, Urbanus RT. J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588 [Abstract] [Full Text] [Related]
30. Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity? Tonello M, Bison E, Cattini MG, Pontara E, Iaccarino L, Denas G, Cheng C, Pengo V. Clin Chem Lab Med; 2021 Nov 25; 59(12):1950-1953. PubMed ID: 34390635 [Abstract] [Full Text] [Related]
31. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I. Sanfelippo MJ, Joshi A, Schwartz S, Meister JA, Goldberg JW. Lupus; 2013 Nov 25; 22(13):1349-52. PubMed ID: 23989738 [Abstract] [Full Text] [Related]
32. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun 25; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
33. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases. Biasiolo A, Rampazzo P, Brocco T, Barbero F, Rosato A, Pengo V. Lupus; 1999 Jun 25; 8(2):121-6. PubMed ID: 10192506 [Abstract] [Full Text] [Related]
34. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity. Pengo V, Brocco T, Biasiolo A, Rampazzo P, Carraro P, Zamarchi R. Blood; 1999 Dec 01; 94(11):3814-9. PubMed ID: 10572096 [Abstract] [Full Text] [Related]
35. Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome. D'Angelo A, Safa O, Crippa L, Garlando A, Sabbadini MG, Vigano' D'Angelo S. Thromb Haemost; 1997 Aug 01; 78(2):967-8. PubMed ID: 9268210 [No Abstract] [Full Text] [Related]
36. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J. Verh K Acad Geneeskd Belg; 2000 Aug 01; 62(5):353-72. PubMed ID: 11144685 [Abstract] [Full Text] [Related]
37. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. J Rheumatol; 1998 Apr 01; 25(4):667-74. PubMed ID: 9558167 [Abstract] [Full Text] [Related]
38. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L. Clin Chem Lab Med; 2015 Jul 01; 53(8):1265-70. PubMed ID: 25562605 [Abstract] [Full Text] [Related]
39. A simple method to discriminate between beta2-glycoprotein I- and prothrombin-dependent lupus anticoagulants. Simmelink MJ, Derksen RH, Arnout J, De Groot PG. J Thromb Haemost; 2003 Apr 01; 1(4):740-7. PubMed ID: 12871410 [Abstract] [Full Text] [Related]